UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

“Trying to Be a Good Parent” As Defined By Interviews With Parents Who Made Phase I, Terminal Care, and Resuscitation Decisions for Their Children

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5979-5985

2009

Volltextzugriff (PDF)

Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

Cancer, 2017-06, Vol.123 (12), p.2360-2367

2017

Volltextzugriff (PDF)

Alveolar soft part sarcoma in children and young adults: A report of 69 cases

Pediatric blood & cancer, 2018-05, Vol.65 (5), p.e26953-n/a

2018

Volltextzugriff (PDF)

End-of-Life Care Preferences of Pediatric Patients With Cancer

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9146-9154

2005

Volltextzugriff (PDF)

A mutational comparison of adult and adolescent and young adult (AYA) colon cancer

Cancer, 2018-03, Vol.124 (5), p.1070-1082

2018

Volltextzugriff (PDF)

Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007

Journal of clinical oncology, 2012-06, Vol.30 (16), p.2005-2012

2012

Volltextzugriff (PDF)

Decision Making by Parents of Children With Incurable Cancer Who Opt for Enrollment on a Phase I Trial Compared With Choosing a Do Not Resuscitate/Terminal Care Option

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3292-3298

2010

Volltextzugriff (PDF)

Phase I Study of Everolimus in Pediatric Patients With Refractory Solid Tumors

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4806-4812

2007

Volltextzugriff (PDF)

Colorectal Carcinoma in Childhood and Adolescence: A Clinicopathologic Review

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5808-5814

2007

Volltextzugriff (PDF)

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors

mAbs, 2020-01, Vol.12 (1), p.1773751

2020

Volltextzugriff (PDF)

Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy

International journal of clinical oncology, 2018-10, Vol.23 (5), p.900-907

2018

Volltextzugriff (PDF)

Monoclonal Antibody Therapies for High Risk Neuroblastoma

Biologics, 2021-01, Vol.15, p.205-219

Furman, Wayne L

2021

Volltextzugriff (PDF)

Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma

Pediatric blood & cancer, 2013-05, Vol.60 (5), p.761-765

2013

Volltextzugriff (PDF)

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000176

2020

Volltextzugriff (PDF)

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A

Journal of clinical oncology, 2022-02, Vol.40 (4), p.335-344

2022

Volltextzugriff (PDF)

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

Clinical cancer research, 2017-11, Vol.23 (21), p.6441-6449

2017

Volltextzugriff (PDF)

UGT1A1 Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan

Journal of clinical oncology, 2007-06, Vol.25 (18), p.2594-2600

2007

Volltextzugriff (PDF)

Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma

Children (Basel), 2021-03, Vol.8 (3), p.226

2021

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4599-4604

2009

Volltextzugriff (PDF)

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience

American journal of roentgenology (1976), 2014-05, Vol.202 (5), p.966-970

2014

Volltextzugriff (PDF)

Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3678-3685

2006

Volltextzugriff (PDF)

A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma

Clinical cancer research, 2019-11, Vol.25 (21), p.6320-6328

2019

Volltextzugriff (PDF)

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial

The lancet oncology, 2019-05, Vol.20 (5), p.719-727

2019

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6172-6180

2005

Volltextzugriff (PDF)

A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors

Cancer, 2009-03, Vol.115 (6), p.1328-1337

2009

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(194)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(149)
Science & Technology
(149)
Humans
(143)
Child
(111)
Oncology
(111)
Male
(105)
Female
(102)
Child, Preschool
(93)
Adolescent
(89)
Biological And Medical Sciences
(71)
Medical Sciences
(70)
Infant
(64)
Pediatrics
(62)
Adult
(52)
Tumors
(43)
Treatment Outcome
(38)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Neuroblastoma
(32)
Hematology
(31)
Neoplasms - Drug Therapy
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

“Trying to Be a Good Parent” As Defined By Interviews With Parents Who Made Phase I, Terminal Care, and Resuscitation Decisions for Their Children

Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

Alveolar soft part sarcoma in children and young adults: A report of 69 cases

End-of-Life Care Preferences of Pediatric Patients With Cancer

A mutational comparison of adult and adolescent and young adult (AYA) colon cancer

Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007

Decision Making by Parents of Children With Incurable Cancer Who Opt for Enrollment on a Phase I Trial Compared With Choosing a Do Not Resuscitate/Terminal Care Option

Phase I Study of Everolimus in Pediatric Patients With Refractory Solid Tumors

Colorectal Carcinoma in Childhood and Adolescence: A Clinicopathologic Review

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors

Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy

Monoclonal Antibody Therapies for High Risk Neuroblastoma

Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

UGT1A1 Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan

Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma

Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience

Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report

A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors

Suchergebnisse filtern